146 related articles for article (PubMed ID: 35948984)
1. Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis.
King C; Patel R; Mendoza C; Walker JK; Wu EY; Moss P; Morgan MD; O'Dell Bunch D; Harper L; Chanouzas D
Arthritis Res Ther; 2022 Aug; 24(1):192. PubMed ID: 35948984
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions.
Yildiz H; Zech F; Hainaut P
Acta Clin Belg; 2016 Aug; 71(4):231-4. PubMed ID: 27141959
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.
Liapi M; Jayne D; Merkel PA; Segelmark M; Mohammad AJ
Rheumatology (Oxford); 2021 Oct; 60(10):4616-4623. PubMed ID: 33506869
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults--a case-control study.
Schimanski S; Linnemann B; Luxembourg B; Seifried E; Jilg W; Lindhoff-Last E; Schambeck CM
Ann Hematol; 2012 Apr; 91(4):597-604. PubMed ID: 21913128
[TBL] [Abstract][Full Text] [Related]
5. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
6. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study.
Moiseev S; Kronbichler A; Makarov E; Bulanov N; Crnogorac M; Direskeneli H; Galesic K; Gazel U; Geetha D; Guillevin L; Hrušková Z; Little MA; Ahmed A; McAdoo SP; Mohammad AJ; Moran S; Novikov P; Pusey CD; Rahmattulla C; Satrapová V; Silva J; Terrier B; Tesař V; Westman K; Jayne DRW
Rheumatology (Oxford); 2021 Oct; 60(10):4654-4661. PubMed ID: 33523099
[TBL] [Abstract][Full Text] [Related]
7. Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
Chanouzas D; Dyall L; Nightingale P; Ferro C; Moss P; Morgan MD; Harper L
Trials; 2016 Jul; 17(1):338. PubMed ID: 27450392
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression.
Hansrivijit P; Trongtorsak A; Gadhiya KP; Lnu K; Dimech CT; Thongprayoon C; Cheungpasitporn W; Lecker SH
Clin Rheumatol; 2021 Jul; 40(7):2843-2853. PubMed ID: 33452661
[TBL] [Abstract][Full Text] [Related]
9. The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis.
Chanouzas D; Sagmeister M; Dyall L; Sharp P; Powley L; Johal S; Bowen J; Nightingale P; Ferro CJ; Morgan MD; Moss P; Harper L
Arthritis Res Ther; 2018 Aug; 20(1):194. PubMed ID: 30157919
[TBL] [Abstract][Full Text] [Related]
10. Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Kronbichler A; Leierer J; Shin JI; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CGM; St Clair EW; Brunetta P; Fervenza FC; Geetha D; Keogh KA; Monach PA; Ytterberg SR; Mayer G; Specks U; Stone JH;
Arthritis Rheumatol; 2019 Nov; 71(11):1888-1893. PubMed ID: 31216123
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with cytomegalovirus infection in antineutrophil cytoplasmic antibody-associated vasculitis: A narrative review.
Leong A; Fong W
Int J Rheum Dis; 2022 Dec; 25(12):1357-1367. PubMed ID: 36135777
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review.
Ceccarelli M; Venanzi Rullo E; Nunnari G
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):381-390. PubMed ID: 29344839
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research.
Nimura T; Aomura D; Harada M; Yamaguchi A; Yamaka K; Nakajima T; Tanaka N; Ehara T; Hashimoto K; Kamijo Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255886
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis following acute cytomegalovirus infection: a community prospective study.
Paran Y; Shalev V; Steinvil A; Justo D; Zimmerman O; Finn T; Berliner S; Zeltser D; Weitzman D; Raz R; Chodick G
Ann Hematol; 2013 Jul; 92(7):969-74. PubMed ID: 23455402
[TBL] [Abstract][Full Text] [Related]
16. CD4
Slot MC; Kroon AA; Damoiseaux JGMC; Theunissen R; Houben AJHM; de Leeuw PW; Tervaert JWC
Rheumatol Int; 2017 May; 37(5):791-798. PubMed ID: 28084533
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Morishita M; Sada KE; Matsumoto Y; Hayashi K; Asano Y; Hiramatsu Asano S; Ohashi K; Miyawaki Y; Katsuyama E; Watanabe H; Kawabata T; Wada J
PLoS One; 2019; 14(7):e0218705. PubMed ID: 31291263
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.
Berti A; Matteson EL; Crowson CS; Specks U; Cornec D
Mayo Clin Proc; 2018 May; 93(5):597-606. PubMed ID: 29588079
[TBL] [Abstract][Full Text] [Related]
19. Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides.
Kronbichler A; Leierer J; Leierer G; Mayer G; Casian A; Höglund P; Westman K; Jayne D;
Rheumatology (Oxford); 2017 May; 56(5):704-708. PubMed ID: 28053275
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study.
Harada M; Iwabuchi R; Yamaguchi A; Aomura D; Yamada Y; Sonoda K; Kamimura Y; Hashimoto K; Kamijo Y
J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
